These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6098610)

  • 1. Renal prostaglandin E in the hypotensive mechanism of MK-421 in conscious rats.
    Yasujima M; Abe K; Tanno M; Kasai Y; Sato K; Tajima J; Kudo K; Tsunoda K; Yoshinaga K
    J Hypertens; 1984 Dec; 2(6):623-9. PubMed ID: 6098610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.
    Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the endogenous angiotensin II in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin.
    Yasujima M; Abe K; Tanno M; Yoshinaga K
    Adv Exp Med Biol; 1989; 247A():35-8. PubMed ID: 2557748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence on significant roles of the prostaglandin-thromboxane and kallikrein-kinin system in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):323-8. PubMed ID: 2440625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats.
    Yasujima M; Abe K; Tanno M; Sato K; Kasai Y; Seino M; Chiba S; Goto T; Omata K; Tajima J
    Clin Exp Hypertens A; 1984; 6(7):1297-310. PubMed ID: 6565534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic effect of norepinephrine, vasopressin and angiotensin II on urinary prostaglandin E and kallikrein excretion in conscious rats].
    Tanno M; Abe K; Yasujima M; Sato K; Omata K; Sato M; Kudo K; Tsunoda K; Kohzuki M; Chiba S
    Nihon Jinzo Gakkai Shi; 1985 Jun; 27(6):825-31. PubMed ID: 3852900
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressor mechanism of enalapril in rats made hypertensive by norepinephrine or vasopressin.
    Yasujima M; Abe K; Tanno M; Kanazawa M; Yoshida K; Sato M; Takeuchi K; Yoshinaga K
    Nephron; 1990; 55 Suppl 1():81-4. PubMed ID: 2345595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of digoxin on blood pressure responses to norepinephrine, angiotensin II and vasopressin in conscious rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kanazawa M; Yoshida K; Omata K; Sato M; Takeuchi K; Hiwatari M
    Tohoku J Exp Med; 1990 Nov; 162(3):203-12. PubMed ID: 2091323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasopressin on rat urinary prostaglandin excretion.
    Ono M; Kogo H; Aizawa Y
    J Pharmacobiodyn; 1982 Apr; 5(4):229-36. PubMed ID: 7120025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic blood pressure responses to enalapril maleate (MK 421, an angiotensin converting enzyme inhibitor) and hydrochlorothiazide in conscious Dahl salt-sensitive and salt-resistant rats.
    Sharma JN; Fernandez PG; Kim BK; Triggle CR
    Can J Physiol Pharmacol; 1984 Jul; 62(7):846-9. PubMed ID: 6093967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B; McGrath BP; Johnston CI
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():99-104. PubMed ID: 6291832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
    Chiba S; Quilley CP; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.